Low Nutritional Prognostic Index Correlates with Poor Survival in Patients with Stage IV Colorectal Cancer Following Palliative Resection of the Primary Tumor

Overview

Journal World J Surg

Publisher Wiley

Specialty General Surgery

Date 2013 Dec 6

PMID 24305937

Citations 27

Authors

Kiyoshi Maeda

Masatsune Shibutani

Hiroshi Otani

Hisashi Nagahara

Kenji Sugano

Teturo Ikeya

Naoshi Kubo

Ryosuke Amano

Kenjiro Kimura

Kazuya Muguruma

Hiroaki Tanaka

Kosei Hirakawa

Affiliations

Soon will be listed here.

Abstract

Background: We retrospectively investigated the prognostic significance of various clinicopathological factors and preoperative nutritional status to select patients with stage IV colorectal cancer (CRC) who will have a poor prognosis after palliative resection of the primary tumor.

Methods: A total of 100 stage IV CRC patients who underwent palliative resection were enrolled. Various clinicopathological factors and Onodera's prognostic nutritional index (OPNI) were evaluated to identify any possible relationship with the prognosis.

Results: At the time of the analysis, 83 patients had died, and the median survival time was 21 months. Of the 100 patients, 24 had primary tumor-related symptoms such as obstruction or bleeding. No significant correlation was noted between the OPNI and various clinicopathological factors. The multivariate analysis of patients without primary tumor-related symptoms revealed that the OPNI was an independent prognostic factor. The overall survival of the low-OPNI group was significantly worse than that of the high-OPNI group.

Conclusions: This retrospective study suggested that patients with a low OPNI may not be candidates for palliative resection, because it provides no survival benefit to these patients.

Citing Articles

Prognostic Significance of C-reactive Protein/Albumin Ratio in Patients with Locally Advanced Unresectable Colorectal Cancer.

Ikeguchi M, Ashida K Indian J Surg Oncol. 2022; 8(3):263-266.

PMID: 36118393 PMC: 9478077. DOI: 10.1007/s13193-017-0639-0.

Prognostic value of combined preoperative prognostic nutritional index and neutrophil to lymphocyte ratio in esophageal squamous cell carcinoma.

Zhang J, Zhang Y, Yv X, Song M, Zhang F, Tian X Transl Cancer Res. 2022; 9(9):5117-5127.

PMID: 35117878 PMC: 8798825. DOI: 10.21037/tcr-19-2397.

Role of the Prognostic Nutritional Index in Patients With Soft-tissue Sarcoma.

Matsuyama Y, Nakamura T, Yoshida K, Nakamura K, Hagi T, Asanuma K In Vivo. 2021; 35(4):2349-2355.

PMID: 34182517 PMC: 8286482. DOI: 10.21873/invivo.12511.

Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.

Takamizawa Y, Shida D, Boku N, Nakamura Y, Ahiko Y, Yoshida T BMC Cancer. 2020; 20(1):1092.

PMID: 33176752 PMC: 7656744. DOI: 10.1186/s12885-020-07560-3.

Pre- and postoperative neutrophil and lymphocyte count and neutrophil-to-lymphocyte ratio in patients with colorectal cancer.

Jakubowska K, Koda M, Kisielewski W, Kanczuga-Koda L, Grudzinska M, Famulski W Mol Clin Oncol. 2020; 13(5):56.

PMID: 32905328 PMC: 7468214. DOI: 10.3892/mco.2020.2126.

References

Damjanov N, Weiss J, Haller D . Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist. 2009; 14(10):963-9. DOI: 10.1634/theoncologist.2009-0022. View

Morise Z, Sugioka A, Fujita J, Hoshimoto S, Kato T, Hasumi A . Does repeated surgery improve the prognosis of colorectal liver metastases?. J Gastrointest Surg. 2005; 10(1):6-11. DOI: 10.1016/j.gassur.2005.09.006. View

Rahbari N, Lordick F, Fink C, Bork U, Stange A, Jager D . Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer. 2012; 12:142. PMC: 3348093. DOI: 10.1186/1471-2407-12-142. View

DeWys W, Begg C, Lavin P, Band P, Bennett J, Bertino J . Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980; 69(4):491-7. DOI: 10.1016/s0149-2918(05)80001-3. View

Van Cutsem E, Kohne C, Hitre E, Zaluski J, Chang Chien C, Makhson A . Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009; 360(14):1408-17. DOI: 10.1056/NEJMoa0805019. View

Kondrup J, Allison S, Elia M, Vellas B, Plauth M . ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003; 22(4):415-21. DOI: 10.1016/s0261-5614(03)00098-0. View

Chapman M, Buckley D, Henson D, Armitage N . Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer. 1998; 78(10):1346-9. PMC: 2063189. DOI: 10.1038/bjc.1998.682. View

Onodera T, Goseki N, KOSAKI G . [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984; 85(9):1001-5. View

Delmore G . Assessment of nutritional status in cancer patients: widely neglected?. Support Care Cancer. 1997; 5(5):376-80. DOI: 10.1007/s005200050095. View

10.

Watanabe M, Iwatsuki M, Iwagami S, Ishimoto T, Baba Y, Baba H . Prognostic nutritional index predicts outcomes of gastrectomy in the elderly. World J Surg. 2012; 36(7):1632-9. DOI: 10.1007/s00268-012-1526-z. View

11.

Chibaudel B, Tournigand C, Andre T, De Gramont A . Therapeutic strategy in unresectable metastatic colorectal cancer. Ther Adv Med Oncol. 2012; 4(2):75-89. PMC: 3296081. DOI: 10.1177/1758834011431592. View

12.

Grothey A, Sargent D, Goldberg R, Schmoll H . Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol. 2004; 22(7):1209-14. DOI: 10.1200/JCO.2004.11.037. View

13.

Pinato D, North B, Sharma R . A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer. 2012; 106(8):1439-45. PMC: 3326674. DOI: 10.1038/bjc.2012.92. View

14.

Katoh H, Yamashita K, Kokuba Y, Satoh T, Ozawa H, Hatate K . Surgical resection of stage IV colorectal cancer and prognosis. World J Surg. 2008; 32(6):1130-7. DOI: 10.1007/s00268-008-9535-7. View

15.

Murry D, Riva L, Poplack D . Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl. 1999; 11:48-51. DOI: 10.1002/(sici)1097-0215(1998)78:11+<48::aid-ijc14>3.0.co;2-3. View

16.

Boleo-Tome C, Monteiro-Grillo I, Camilo M, Ravasco P . Validation of the Malnutrition Universal Screening Tool (MUST) in cancer. Br J Nutr. 2011; 108(2):343-8. DOI: 10.1017/S000711451100571X. View

17.

Nozoe T, Kohno M, Iguchi T, Mori E, Maeda T, Matsukuma A . The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today. 2011; 42(6):532-5. DOI: 10.1007/s00595-011-0061-0. View

18.

Zhang Y, Gu Y, Guo T, Li Y, Cai H . Perioperative immunonutrition for gastrointestinal cancer: a systematic review of randomized controlled trials. Surg Oncol. 2012; 21(2):e87-95. DOI: 10.1016/j.suronc.2012.01.002. View

19.

Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A . Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009; 30(7):1073-81. DOI: 10.1093/carcin/bgp127. View

20.

Konyalian V, Rosing D, Haukoos J, Dixon M, Sinow R, Bhaheetharan S . The role of primary tumour resection in patients with stage IV colorectal cancer. Colorectal Dis. 2007; 9(5):430-7. DOI: 10.1111/j.1463-1318.2007.01161.x. View